SMS Pharmaceuticals Limited (NSE:SMSPHARMA)
India
· Delayed Price · Currency is INR | Market Cap | 21.30B |
| Revenue (ttm) | 7.80B |
| Net Income (ttm) | 660.99M |
| Shares Out | 88.65M |
| EPS (ttm) | 7.82 |
| PE Ratio | 30.73 |
| Forward PE | n/a |
| Dividend | 0.40 (0.17%) |
| Ex-Dividend Date | Sep 23, 2024 |
| Volume | 79,684 |
| Average Volume | 194,959 |
| Open | 240.24 |
| Previous Close | 240.24 |
| Day's Range | 233.00 - 240.24 |
| 52-Week Range | 175.25 - 398.00 |
| Beta | 1.23 |
| RSI | 64.36 |
| Earnings Date | May 27, 2025 |
About SMS Pharmaceuticals
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. The company offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyde... [Read more]
Financial Performance
Financial StatementsNews
Stocks to Watch on Oct 3: Reliance Power, Ashoka Buildcon, CESC, SMS Pharma, PVR INOX, Zydus Lifesciences, Reliance Infra, and HealthCare Global in focus
Key stocks to watch include Ashoka Buildcon, CESC, SMS Pharmaceuticals, PVR INOX, HealthCare Global Enterprises, Zydus Lifesciences, Reliance Power, Reliance Infra, Vikas Lifecare, Eraaya Lifespaces, ...
SMS Pharmaceuticals receives EDQM certification to supply Ibuprofen in Europe
SMS Pharmaceuticals Limited (NSE: SMSPHARMA; BSE: 532815) has received the European Directorate for the Quality of Medicines & HealthCare (EDQM) certification to supply Ibuprofen from its Visakhapatna...